Complete Filing Data
ARS Pharmaceuticals, Inc. reported Stockholders Equity of $114.26 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean ARS Pharmaceuticals, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income Loss | -$171.3M | $8.0M | -$54.4M | -$34.7M | -$20.2M | -$32.9M |
| Comprehensive Income Net Of Tax | -$171.4M | $8.2M | -$54.7M | -$34.3M | -$20.2M | -$32.9M |
| Research And Development Expense | $13.2M | $19.6M | $20.3M | $18.4M | $20.3M | $24.6M |
| Operating Income Loss | -$179.4M | -$3.1M | -$67.5M | -$35.5M | -$19.5M | -$32.9M |
| Operating Expenses | $263.7M | $92.2M | $67.6M | $36.8M | $25.0M | $32.9M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$95.0K | $171.0K | -$358.0K | $407.0K | $0.00 | $0.00 |
| General And Administrative Expense | $47.3M | $18.5M | $4.7M | $8.3M | ||
| Other Comprehensive Income Loss Net Of Tax | $8.2M | -$54.7M | -$34.3M | -$20.2M | -$32.9M | |
| Revenue From Contract With Customer Excluding Assessed Tax | $84.3M | $89.1M | $30.0K | $1.3M | $5.5M | |
| Other Nonoperating Income Expense | $8.1M | $11.4M | $13.2M | $974.0K | -$789.0K | |
| Selling General And Administrative Expense | $230.1M | $71.7M | $47.3M | $603.0K | ||
| Interest Income Expense Net | $106.0K | -$29.0K | ||||
| Cost Of Goods Sold Operating Expense | $20.4M | $977.0K | $0.00 | |||
| Cost Of Goods And Services Sold | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$51.2M | -$44.9M | -$33.9M | -$19.1M | -$12.5M | -$10.3M | -$14.9M | -$17.4M | -$15.0M | -$6.6M | -$6.4M | -$7.3M | -$22.7M | -$24.5M | -$18.9M | -$8.1M | -$6.5M | -$5.3M |
| Comprehensive Income Net Of Tax | -$51.1M | -$45.0M | -$34.1M | -$18.6M | -$12.5M | -$10.5M | -$14.8M | -$17.6M | -$15.3M | -$6.6M | -$6.4M | -$7.3M | -$22.7M | -$24.5M | -$18.9M | -$8.1M | ||
| Research And Development Expense | $2.8M | $4.0M | $3.0M | $4.4M | $6.9M | $5.2M | $3.0M | $7.3M | $6.6M | $3.9M | $4.4M | $5.4M | $15.6M | $17.7M | $12.2M | $6.2M | $5.1M | $4.4M |
| Operating Income Loss | -$53.2M | -$47.6M | -$37.2M | -$21.7M | -$15.3M | -$13.2M | -$18.0M | -$20.6M | -$18.7M | -$6.6M | -$6.3M | -$7.1M | -$22.7M | -$24.5M | -$18.9M | -$8.1M | -$6.5M | -$5.2M |
| Operating Expenses | $85.7M | $63.3M | $45.2M | $23.8M | $15.8M | $13.2M | $18.0M | $20.6M | $18.7M | $6.8M | $6.8M | $7.8M | $22.7M | $24.5M | $18.9M | $8.1M | $6.5M | $5.2M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $39.0K | -$118.0K | -$148.0K | $484.0K | -$21.0K | -$173.0K | $19.0K | -$248.0K | -$339.0K | $0.00 | $0.00 | $0.00 | -$34.0K | $0.00 | $0.00 | $0.00 | ||
| General And Administrative Expense | $8.9M | $8.0M | $15.0M | $13.3M | $12.2M | $2.9M | $2.5M | $2.3M | $7.0M | $6.8M | $6.6M | $1.9M | $1.3M | $828.0K | ||||
| Other Comprehensive Income Loss Net Of Tax | -$18.6M | -$12.5M | -$10.5M | -$14.8M | -$17.6M | -$15.3M | -$6.6M | -$6.4M | -$7.3M | -$22.7M | -$24.5M | -$18.9M | -$8.1M | -$6.5M | -$5.3M | |||
| Revenue From Contract With Customer Excluding Assessed Tax | $32.5M | $15.7M | $8.0M | $2.1M | $500.0K | $0.00 | $0.00 | $10.0K | $20.0K | $189.0K | $464.0K | $663.0K | ||||||
| Other Nonoperating Income Expense | $2.0M | $2.7M | $3.2M | $2.6M | $2.8M | $2.9M | $3.1M | $3.2M | $3.8M | $47.0K | -$76.0K | -$151.0K | ||||||
| Selling General And Administrative Expense | $74.8M | $54.3M | $41.1M | $19.3M | $8.9M | $8.0M | $15.0M | $181.0K | $337.0K | |||||||||
| Interest Income Expense Net | $1.1M | $369.0K | $67.0K | $26.0K | $15.0K | $18.0K | -$4.0K | -$4.0K | -$37.0K | |||||||||
| Cost Of Goods Sold Operating Expense | $8.2M | $5.0M | $1.1M | $112.0K | $0.00 | $0.00 | $0.00 | |||||||||||
| Cost Of Goods And Services Sold |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $114.3M | $256.8M | $230.8M | $272.9M | -$31.3M | -$14.1M | -$58.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $41.3M | $50.8M | $71.0M | $210.5M | $60.1M | $24.5M | $10.5M |
| Retained Earnings Accumulated Deficit | -$294.6M | -$123.3M | -$131.3M | -$76.9M | -$42.3M | -$96.7M | |
| Property Plant And Equipment Net | $2.5M | $1.1M | $574.0K | $329.0K | $72.0K | $1.6M | |
| Prepaid Expense And Other Assets Current | $6.2M | $6.9M | $3.4M | $3.3M | $667.0K | $4.1M | |
| Liabilities Current | $39.1M | $23.4M | $2.4M | $5.4M | $8.2M | $9.6M | |
| Liabilities And Stockholders Equity | $327.7M | $351.2M | $233.2M | $281.4M | $61.4M | $394.8M | |
| Liabilities | $213.4M | $94.4M | $2.4M | $8.5M | $16.7M | $11.9M | |
| Common Stock Value | $10.0K | $10.0K | $10.0K | $9.0K | $3.0K | $3.0K | |
| Cash And Cash Equivalents At Carrying Value | $41.3M | $50.8M | $71.0M | $210.5M | $60.1M | $386.6M | |
| Assets Current | $284.9M | $334.3M | $231.7M | $277.7M | $60.7M | $390.7M | |
| Assets | $327.7M | $351.2M | $233.2M | $281.4M | $61.4M | $394.8M | |
| Operating Lease Right Of Use Asset | $250.0K | $445.0K | $621.0K | $2.2M | |||
| Operating Lease Liability Current | $237.0K | $230.0K | $144.0K | $896.0K | |||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Operating Lease Liability Noncurrent | $37.0K | $251.0K | $480.0K | $2.3M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $125.0K | $220.0K | $49.0K | $407.0K | $0.00 | $0.00 | |
| Short Term Investments | $203.7M | $263.2M | $157.4M | $63.9M | $0.00 | ||
| Other Assets | $2.8M | $3.1M | $638.0K | $3.0M | $23.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$9.5M | -$20.2M | -$139.5M | $150.5M | $35.5M | ||
| Accounts Payable And Accrued Liabilities Current | $37.9M | $22.8M | $2.2M | $4.9M | $3.1M | ||
| Operating Right Of Use Assets And Lease Liabilities | -$19.0K | -$12.0K | $33.0K | $4.0K | |||
| Contract With Customer Liability Noncurrent | $1.1M | $1.5M | $0.00 | $2.9M | $3.0M | ||
| Contract With Customer Liability Current | $609.0K | $557.0K | $0.00 | $283.0K | $1.5M | ||
| Other Receivables Net Current | $178.0K | $16.0K | |||||
| Capital Expenditures Reclassed From Prepaid Expenses And Other Current Assets | $0.00 | $174.0K | $0.00 | ||||
| Restricted Cash Noncurrent | $350.0K | ||||||
| Repayments Of Bank Debt | $846.0K | $700.0K | |||||
| Operating Lease Right Of Use Asset Amortization Expense | $1.1M | $1.1M | |||||
| Accrued Liabilities Current | $5.3M | ||||||
| Accounts Payable Current | $2.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $147.7M | $192.3M | $229.0M | $201.0M | $215.2M | $223.9M | $237.3M | $248.6M | $261.2M | -$50.2M | -$44.0M | -$38.3M | $332.1M | $349.7M | $368.5M | -$78.2M | -$70.3M | -$64.0M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $59.6M | $51.5M | $39.9M | $39.7M | $36.6M | $56.0M | $60.5M | $119.0M | $87.9M | $37.3M | $44.6M | $52.2M | $301.0M | $360.0M | $374.6M | $142.9M | $30.7M | $24.2M | ||
| Retained Earnings Accumulated Deficit | -$253.3M | -$202.1M | -$157.2M | -$173.2M | -$154.1M | -$141.6M | -$124.1M | -$109.3M | -$91.9M | -$248.1M | -$230.3M | -$210.8M | -$162.8M | -$140.1M | -$115.6M | |||||
| Property Plant And Equipment Net | $1.2M | $1.1M | $1.1M | $843.0K | $636.0K | $616.0K | $617.0K | $594.0K | $584.0K | $15.0K | $2.5M | $2.4M | $1.9M | $2.0M | $1.6M | |||||
| Prepaid Expense And Other Assets Current | $6.4M | $7.4M | $11.6M | $2.7M | $2.0M | $2.6M | $2.6M | $2.8M | $2.8M | $4.2M | $5.2M | $7.5M | $4.7M | $3.3M | $4.1M | |||||
| Liabilities Current | $50.9M | $45.6M | $27.6M | $16.6M | $6.7M | $3.7M | $11.2M | $10.1M | $9.8M | $4.0M | $11.1M | $14.8M | $15.3M | $15.5M | $11.6M | |||||
| Liabilities And Stockholders Equity | $372.8M | $313.5M | $327.3M | $217.6M | $222.0M | $227.6M | $248.6M | $258.8M | $271.2M | $271.1M | $294.0M | $312.5M | $352.6M | $367.0M | $382.2M | |||||
| Liabilities | $225.1M | $121.2M | $98.3M | $16.6M | $6.7M | $3.7M | $11.3M | $10.2M | $10.0M | $4.0M | $15.2M | $19.2M | $20.4M | $17.3M | $13.7M | |||||
| Common Stock Value | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $9.0K | $9.0K | $9.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | |||||
| Cash And Cash Equivalents At Carrying Value | $59.6M | $51.5M | $39.9M | $39.7M | $36.6M | $56.0M | $60.5M | $119.0M | $87.9M | $203.2M | $218.7M | $234.0M | $300.7M | $359.7M | $374.2M | |||||
| Assets Current | $338.9M | $281.4M | $303.9M | $208.8M | $220.7M | $226.2M | $244.5M | $255.0M | $267.4M | $270.8M | $263.1M | $261.3M | $305.4M | $363.0M | $378.3M | |||||
| Assets | $372.8M | $313.5M | $327.3M | $217.6M | $222.0M | $227.6M | $248.6M | $258.8M | $271.2M | $271.1M | $294.0M | $312.5M | $352.6M | $367.0M | $382.2M | |||||
| Operating Lease Right Of Use Asset | $1.4M | $1.6M | $72.0K | $37.0K | $92.0K | $146.0K | $198.0K | $300.0K | $349.0K | $398.0K | $0.00 | $3.9M | $4.5M | $5.0M | $1.6M | $1.9M | ||||
| Operating Lease Liability Current | $583.0K | $589.0K | $73.0K | $42.0K | $102.0K | $160.0K | $217.0K | $235.0K | $233.0K | $232.0K | $215.0K | $881.0K | $1.1M | $1.1M | $958.0K | $927.0K | ||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Operating Lease Liability Noncurrent | $949.0K | $1.1M | $0.00 | $0.00 | $0.00 | $0.00 | $92.0K | $146.0K | $199.0K | $0.00 | $4.1M | $4.4M | $5.1M | $1.8M | $2.1M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$7.0K | -$46.0K | $72.0K | $339.0K | -$145.0K | -$124.0K | -$161.0K | -$180.0K | $68.0K | -$1.6M | -$1.5M | -$1.2M | -$34.0K | |||||||
| Short Term Investments | $228.7M | $188.6M | $235.9M | $165.0M | $182.1M | $167.6M | $181.4M | $133.2M | $176.7M | $63.4M | $39.3M | $19.9M | ||||||||
| Other Assets | $2.9M | $3.1M | $3.1M | $377.0K | $446.0K | $528.0K | $3.2M | $2.8M | $2.9M | |||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$11.0M | -$15.0M | -$122.7M | -$7.9M | ||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | $49.8M | $44.3M | $27.0M | $16.5M | $6.6M | $3.5M | $10.9M | $9.8M | $9.6M | |||||||||||
| Operating Right Of Use Assets And Lease Liabilities | -$4.0K | -$5.0K | -$3.0K | $37.0K | ||||||||||||||||
| Contract With Customer Liability Noncurrent | $1.3M | $1.1M | $1.3M | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Contract With Customer Liability Current | $526.0K | $746.0K | $540.0K | $0.00 | $0.00 | $10.0K | ||||||||||||||
| Other Receivables Net Current | $4.3M | $1.1M | $710.0K | $656.0K | $133.0K | $122.0K | $280.0K | $208.0K | ||||||||||||
| Capital Expenditures Reclassed From Prepaid Expenses And Other Current Assets | $0.00 | $174.0K | $0.00 | |||||||||||||||||
| Restricted Cash Noncurrent | $250.0K | $250.0K | $250.0K | $250.0K | $350.0K | $350.0K | $350.0K | |||||||||||||
| Repayments Of Bank Debt | $0.00 | $350.0K | $350.0K | |||||||||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $249.0K | $280.0K | $262.0K | |||||||||||||||||
| Accrued Liabilities Current | $3.6M | $8.1M | $11.1M | $11.7M | $12.5M | $12.8M | $5.8M | |||||||||||||
| Accounts Payable Current | $126.0K | $2.1M | $2.6M | $2.1M | $1.7M | $1.8M | $4.4M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $22.1M | $14.5M | $9.2M | $5.8M | $2.8M | $2.6M |
| Payments To Acquire Property Plant And Equipment | $339.0K | $563.0K | $175.0K | $199.0K | $55.0K | $917.0K |
| Net Cash Provided By Used In Operating Activities | -$170.9M | $13.5M | -$59.3M | -$40.1M | -$17.6M | -$31.2M |
| Net Cash Provided By Used In Investing Activities | $56.8M | -$106.1M | -$87.2M | -$199.0K | -$55.0K | -$917.0K |
| Net Cash Provided By Used In Financing Activities | $104.6M | $72.4M | $6.9M | $190.7M | $53.2M | $408.5M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$656.0K | $6.2M | $1.4M | $1.2M | -$1.2M | $3.5M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $18.9M | $16.4M | -$2.8M | -$10.3M | $974.0K | $1.8M |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 5.7M | 3.0M | 6.9M | 570.0K | 169.0K | 177.0K |
| Payments To Acquire Short Term Investments | $242.0M | $356.0M | $272.0M | $0.00 | $0.00 | |
| Increase Decrease In Contract With Customer Liability | -$350.0K | $2.1M | -$3.1M | -$1.3M | -$2.5M | |
| Proceeds From Sale Of Short Term Investments | $307.0M | $258.0M | $185.0M | $0.00 | ||
| Increase Decrease In Due To Related Parties | $478.0K | $162.0K | -$143.0K | $13.0K | ||
| Net Cash Provided By Used In Continuing Operations | -$132.6M | $376.4M | ||||
| Increase Decrease In Operating Lease Liabilities | -$1.1M | -$885.0K | ||||
| Increase Decrease In Donation Of Equipment | -$30.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $5.7M | $5.4M | $5.3M | $3.6M | $3.4M | $3.3M | $2.3M | $264.0K | $4.3M | $47.0K |
| Payments To Acquire Property Plant And Equipment | $91.0K | $83.0K | $193.0K | $21.0K | $35.0K | $33.0K | ||||
| Net Cash Provided By Used In Operating Activities | -$40.7M | -$6.7M | -$12.4M | -$6.9M | -$12.2M | -$7.6M | ||||
| Net Cash Provided By Used In Investing Activities | $29.1M | -$8.5M | -$111.5M | -$21.0K | -$35.0K | -$33.0K | ||||
| Net Cash Provided By Used In Financing Activities | $725.0K | $258.0K | $1.3M | -$908.0K | -$128.0K | $21.3M | ||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $4.8M | -$867.0K | -$445.0K | -$92.0K | $54.0K | -$92.0K | ||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $4.2M | $1.3M | $4.8M | $546.0K | $2.2M | -$2.7M | ||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 725.0K | 258.0K | 1.3M | 0.00 | 222.0K | |||||
| Payments To Acquire Short Term Investments | $34.3M | $63.4M | $131.4M | $0.00 | ||||||
| Increase Decrease In Contract With Customer Liability | -$210.0K | $0.00 | -$3.1M | -$663.0K | ||||||
| Proceeds From Sale Of Short Term Investments | $63.5M | $55.0M | $20.0M | $0.00 | ||||||
| Increase Decrease In Due To Related Parties | $102.0K | $291.0K | $55.0K | |||||||
| Net Cash Provided By Used In Continuing Operations | -$20.1M | -$12.4M | $13.7M | |||||||
| Increase Decrease In Operating Lease Liabilities | -$293.0K | -$240.0K | -$212.0K | |||||||
| Increase Decrease In Donation Of Equipment | $0.00 | -$30.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.74 | $0.08 | -$0.57 | -$0.87 | -$0.70 | -$11.33 |
| Weighted Average Number Of Shares Outstanding Basic | 98.6M | 96.9M | 95.2M | 40.0M | 28.9M | |
| Weighted Average Number Of Diluted Shares Outstanding | 98.6M | 102.4M | 95.2M | 40.0M | 28.9M | |
| Earnings Per Share Basic | $-1.74 | $0.08 | $-0.57 | $-0.87 | $-0.70 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 99.3M | 98.0M | 96.4M | 93.9M | 30.4M | 34.7M |
| Common Stock Shares Issued | 99.3M | 98.0M | 96.4M | 93.9M | 30.4M | 34.8M |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 56.0M | 200.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 34.9M | 2.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.52 | -$0.46 | -$0.35 | -$0.20 | -$0.13 | -$0.11 | -$0.16 | -$0.18 | -$0.16 | -$0.21 | -$0.21 | -$0.24 | -$0.65 | -$0.70 | -$0.54 | -$11.97 | -$9.65 | -$7.89 |
| Weighted Average Number Of Shares Outstanding Basic | 98.8M | 98.4M | 98.1M | 97.0M | 96.8M | 96.5M | 95.6M | 94.9M | 94.2M | 30.8M | 30.6M | 30.4M | 35.0M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 98.8M | 98.4M | 98.1M | 97.0M | 96.8M | 96.5M | 95.6M | 94.9M | 94.2M | 30.8M | 30.6M | 30.4M | 35.0M | |||||
| Earnings Per Share Basic | $-0.52 | $-0.46 | $-0.35 | $-0.20 | $-0.13 | $-0.11 | $-0.16 | $-0.18 | $-0.16 | $-0.21 | $-0.21 | $-0.24 | $-0.65 | |||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 98.8M | 98.7M | 98.1M | 97.1M | 96.9M | 96.6M | 95.8M | 95.3M | 94.4M | 35.9M | 35.2M | 35.1M | 35.0M | 35.0M | 34.8M | |||
| Common Stock Shares Issued | 98.8M | 98.7M | 98.1M | 97.1M | 96.9M | 96.6M | 95.8M | 95.3M | 94.4M | 35.9M | 35.2M | 35.1M | 35.1M | 35.0M | 34.9M | |||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 35.1M | 35.1M | 35.0M | 34.9M | 34.8M | 678.0K | 670.5K | 669.0K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $23.2M | $14.9M | $9.3M | $5.8M | $2.8M | $2.6M |
| Additional Paid In Capital | $408.7M | $379.9M | $362.0M | $349.4M | $11.0M | $479.6M |
| Stock Issued During Period Value Stock Options Exercised | $169.0K | $55.0K | ||||
| Depreciation | $79.0K | $73.0K | $34.0K | $783.0K | $637.0K | |
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $91.0K | $0.00 | |||
| Operating Costs And Expenses | $2.1M | $1.8M | $2.1M | |||
| Stock Issued During Period Shares Stock Options Exercised | 548.8K | 261.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $6.0M | $5.7M | $5.5M | $3.7M | $3.4M | $3.3M | $2.7M | $2.2M | $2.3M | $460.0K | $356.0K | $264.0K | $5.0M | $4.7M | $4.3M | $191.0K | $128.0K | $47.0K |
| Additional Paid In Capital | $400.9M | $394.5M | $386.1M | $373.9M | $369.5M | $365.6M | $361.6M | $358.0M | $353.0M | $516.8M | $510.6M | $505.3M | $494.9M | $489.7M | $484.1M | |||
| Stock Issued During Period Value Stock Options Exercised | $479.0K | $922.0K | $2.7M | $1.3M | $287.0K | $19.0K | $154.0K | $254.0K | $16.0K | $2.0K | $6.0K | |||||||
| Depreciation | $11.0K | $20.0K | $50.0K | $186.0K | $139.0K | |||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $91.0K | $21.0K | $136.0K | ||||||||||||||
| Operating Costs And Expenses | $406.0K | $518.0K | $726.0K | $307.0K | $484.0K | $591.0K | ||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 502.7K | 11.3K | 102.0K |
Most recent annual filing with the SEC: March 9, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.